News Center

Discover all of the trending news of the Ipsen Group


12 results

Financial information

Ipsen – Half Year 2020 Sales Conference Call – Thursday, July 30, 2020

Dear All, David Loew, Chief Executive Officer, is pleased to host a conference call to…

Group

David Loew joins Ipsen as CEO

We are delighted to welcome David Loew as the new CEO of Ipsen. A seasoned…

CSR

One year later: How are we doing with our Environmental, Social and Governance (ESG) criteria for external financing?

In 2019, for the first time, Ipsen committed to introduce Environmental, Social and Governance (ESG)…

People

Ipsen Alliance Management Team Receives Prestigious 2020 ASAP Award of Excellence for Long-term Established Partnerships

Last summer, Ipsen, headquartered in Boulogne, France and Debiopharm, headquartered in Lausanne, Switzerland announced…

Event Oncology

ASCO 2020: A virtual success

We have just completed the first-ever virtual ASCO Annual Meeting.  It is amazing that ASCO…

Oncology

World Kidney Cancer Day: We need to talk

World Kidney Cancer Day is taking place on 18 June 2020, and this year we…

People

CEO of North America, Richard Paulson, Reflects on the Death of George Floyd

Yesterday, Richard Paulson, CEO of North America, joined other biotech and industry leaders by sharing…

Rare diseases

Ipsen in Rare Diseases: Why will fun feet help drive diagnoses of FOP?

Jim Roach MD, FACP, FCCP, SVP and Global Head, Rare Diseases Therapeutic Area, Ipsen Rare…

Group Patient

Fulfilling our commitment to employees and mission to patients in the context of the COVID-19 pandemic

As the COVID-19 pandemic reaches a critical stage in several countries around the world, we…

CSR People

International Women’s Day 2020: For real equality!

Is a company a societal microcosm? Today, a company cannot escape the debates that shake…

Rare diseases

Celebrating Ipsen Rare Disease Day 2020

Ipsen, we are determined to show our commitment to patients with rare diseases including acromegaly,…

Financial information Group

FY2019 and beyond: paving the way for our next phase of growth.

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020